Unravelling the synergistic potential of Olibanum extract and Bacillus clausii in combating intestinal cryptosporidiosis in immunosuppressed mice
PLOS Neglected Tropical Diseases · 2026
DOI: 10.1371/journal.pntd.0014734 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2026. Verfasst von Fadwa M Arafa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Parasitology, Faculty of Medicine, Alexandria University, Alexandria, Egypt. Hauptthemen laut MEDLINE: Cryptosporidiosis, Bacillus clausii, Probiotics. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Given the grave risk posed by intestinal cryptosporidiosis to vulnerable populations, the current research focused on a new therapeutic avenue. Olibanum (OL) extract and probiotic Bacillus clausii ( B. clausii ) and their combination were evaluated against Cryptosporidium in vivo in immunosuppressed mice via parasitological, ultrastructural, biochemical, and histopathological analysis. Liquid chromatography-mass spectrometry (LC–MS) analysis of OL revealed the predominance of incensole isomers in its chemical composition. Regarding oocyst count in stool, the highest percentage of oocyst reduction was achieved after combined therapy (98.4%) on the 19 th day post-infection, followed by B. clausii- treated group (87.6%), then the OL-treated group (87%). Similar ultrastructural alterations were noticed by scanning electron microscopy (SEM) following treatment by both OL and B. clausii , ranging from shrunken oocysts to severely deformed ones with extensive pits or protrusions. Nonetheless, their combination resulted in complete distortion of the oocysts, leading to their rupture. Biochemically, both OL and B. clausii treatment, either alone or in combination, provoked a decrease in the serum MDA levels, together with a corresponding rise in the mean levels of GSH. Concerning the histopathological findings, the best results were achieved following the combined OL and B. clausii treatment, which has restored villus architecture and remarkably ameliorated detrimental intestinal inflammation and goblet cell count. Finally, immunohistochemical analysis of the lymphocytic population of the intestinal villi revealed a statistically significant rise in the CD4+ /CD8+ ratio after treatment with either OL, B. clausii or their combination, which signals their proficient use for this therapeutic endeavour.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medical Parasitology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
- Department of Chemistry, Faculty of Science, Alexandria University, Alexandria, Egypt.
- Department of Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
ORCID-Profile: Fadwa M Arafa
Zitieren
APA
Arafa, F. M., Hagar, M., Zakaria, A., Sheta, E., & Hezema, N. N. (2026). Unravelling the synergistic potential of Olibanum extract and Bacillus clausii in combating intestinal cryptosporidiosis in immunosuppressed mice. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0014734
Vancouver
Arafa FM, Hagar M, Zakaria A, Sheta E, Hezema NN. Unravelling the synergistic potential of Olibanum extract and Bacillus clausii in combating intestinal cryptosporidiosis in immunosuppressed mice. PLOS Neglected Tropical Diseases. 2026. doi:10.1371/journal.pntd.0014734
BibTeX
@article{Arafa2026,
author = {Arafa, Fadwa M and Hagar, Mohamed and Zakaria, Ahmed and Sheta, Eman and Hezema, Nehal N},
title = {Unravelling the synergistic potential of Olibanum extract and Bacillus clausii in combating intestinal cryptosporidiosis in immunosuppressed mice},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
doi = {10.1371/journal.pntd.0014734}
}
EUVIMED